Add BrightSurf on Google Email

UW Medicine scientists among leads of NIH pangenome studies

The Human Pangenome Reference Consortium expands and updates the human genome project with nearly full genomic data from 47 people of diverse ancestry. Researchers at UW Medicine made significant contributions to drafting the pangenome reference and studying variation within repetitive DNA, which could improve equity in human genome re...

SourceUniversity of Washington School of Medicine/UW Medicine·JournalNature·TypeExperimental study·DateMay 10, 2023

Wakefulness-promoting agents effective for excessive daytime sleepiness but patients may discontinue due to side effects

Researchers found that solriamfetol, armodafinil–modafinil, and pitolisant reduce excessive daytime sleepiness in patients with obstructive sleep apnea already using conventional therapy. However, patients may be more likely to discontinue the use of these medications due to adverse events including headache, anxiety, and insomnia.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeLiterature review·DateMay 8, 2023

Gene responsible for severe facial defects identified

A team of researchers from UNIGE and Beihang University has identified the FOXI3 gene as responsible for one form of Goldenhar syndrome, a rare congenital disorder. Pathogenic variants in both copies of the FOXI3 gene are necessary for the disease to develop, following an autosomal recessive inheritance pattern.

SourceUniversité de Genève·JournalNature Communications·TypeNews article·DateMay 4, 2023

New Family Heart Foundation study reveals systemic underdiagnosis and undertreatment of homozygous familial hypercholesterolemia

A new study reveals delayed diagnosis of HoFH leads to premature cardiovascular disease, highlighting the need for increased lipid screening and aggressive treatment. Despite available therapies, most patients require further lipid-lowering treatments.

SourceFamily Heart Foundation·JournalJournal of the American Heart Association·TypeObservational study·DateMay 2, 2023

5,500 people diagnosed with rare genetic diseases in major research study

A nationwide UK research study has diagnosed around 5,500 children with severe developmental disorders, identifying the genetic cause of their condition. The Deciphering Developmental Disorders study used genomic sequencing technology to provide diagnoses for families from across the UK and Ireland.

SourceUniversity of Exeter·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateApr 12, 2023

Could a vitamin deficiency cause ‘double-jointedness’ and hypermobile Ehlers-Danlos syndrome?

Tulane University researchers discovered a possible genetic cause of hypermobility and hypermobile Ehlers-Danlos syndrome, linking it to folate deficiency due to the MTHFR gene variation. Elevated folate levels in blood tests can aid in diagnosis, while methylated folate has shown promising treatment results for patients.

SourceTulane University·JournalHeliyon·TypeObservational study·DateApr 9, 2023

Survey of allergists/immunologists reveals management of hereditary angioedema differs by region

A survey of allergists and immunologists reveals that diagnosing and treating hereditary angioedema can be challenging, particularly for patients in rural areas. Patients living in rural areas are more likely to face barriers to care, including longer travel times to reach medical facilities.

SourceAmerican College of Allergy, Asthma, and Immunology·JournalAnnals of Allergy Asthma & Immunology·TypeSurvey·DateApr 5, 2023

Researchers develop a drug effective in a rare hereditary muscle disease, as well as in severe statin-associated muscle disease

Researchers have discovered a novel medication that effectively treats a rare hereditary muscle disease causing complete immobility and death. The treatment has also shown promise in treating severe statin-associated myopathy, with improved symptoms in patients awaiting treatment.

SourceBen-Gurion University of the Negev·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 21, 2023

New gene-editing technique reverses vision loss in mice

Researchers have successfully restored vision in mice with retinitis pigmentosa using a new CRISPR-based genome editing technique. The PE SpRY system corrected genetic mutations and restored normal electrical responses to light, preserving vision into old age. This breakthrough offers potential for treating inherited blindness.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·TypeExperimental study·DateMar 17, 2023

Alexander M. Holtz, MD, PhD receives the 2023 Richard King Award for Best Publication by a Trainee in Genetics in Medicine

Dr. Alexander M. Holtz received the award for his published article on heterozygous variants in MYH10 associated with neurodevelopmental disorders and congenital anomalies. The study highlights primary cilia-dependent defects in Hedgehog signaling, shedding light on a previously unknown autosomal dominant condition.

Cause of leukemia in trisomy 21

Children with Down syndrome are highly vulnerable to developing aggressive leukaemia due to a defect in the RUNX1 gene, which regulates blood cell formation. Researchers have identified a specific variant of the gene that promotes leukaemia development and discovered potential therapeutic approaches to correct this malfunction.

SourceGoethe University Frankfurt·JournalBlood·TypeExperimental study·DateMar 10, 2023

Grey hair and wrinkles at an early age led researchers to new treatment for rare cancer

Researchers have identified a new method to predict which sarcoma patients will benefit from a potential new treatment. By inhibiting the plk1 gene, they were able to target and slow down the growth of sarcoma cells. This breakthrough could lead to improved treatment options for sickest sarcoma patients in 5-10 years.

SourceUniversity of Copenhagen - The Faculty of Health and Medical Sciences·JournalCell Death and Disease·TypeExperimental study·DateMar 8, 2023

Hope for patients with a severe rare disease

A team of scientists from ETH Zurich has developed a new diagnostic strategy for methylmalonic aciduria (MMA), a rare metabolic disorder affecting approximately one in 90,000 newborns. The approach, which considers genetic, RNA, protein, and metabolomics data, correctly diagnosed 84% of patients examined.

SourceETH Zurich·JournalNature Metabolism·TypeExperimental study·DateJan 26, 2023

Aging | Genetic deficiency and pharmacological modulation of RORα regulate laser-induced choroidal neovascularization

In a mouse model of laser-induced CNV, RORα expression was highly increased in the choroidal/RPE complex post-laser, while loss or inhibition of RORα worsened CNV with increased lesion size and vascular leakage. RORα negatively regulates pathological CNV development by modulating angiogenic response and inflammatory environment.

SourceImpact Journals LLC·JournalAging-US·TypeObservational study·DateJan 18, 2023

How differences in diagnoses of mental disorders might affect clinical research outcomes for antipsychotics

A study from Japan found that variations in psychiatric diagnoses across different cultures can affect the efficacy of antipsychotics in clinical trials. Researchers analyzed data from 28 double-blind randomized trials and found that psychotic features were associated with varying therapeutic responses to antipsychotic medications.

SourceFujita Health University·JournalPsychiatry and Clinical Neurosciences·TypeMeta-analysis·DateJan 10, 2023

Weiss-Kruszka syndrome and the failure to establish neuronal identity

Researchers identified the molecular mechanism underlying Weiss-Kruszka syndrome, a rare neurodevelopmental disorder characterized by craniofacial anomalies and autistic features. The study reveals that the ZFP462 gene mutation leads to a failure to safeguard neural lineage specification during early embryonic development.

SourceIMBA- Institute of Molecular Biotechnology of the Austrian Academy of Sciences·JournalNature Cell Biology·TypeExperimental study·DateJan 5, 2023

A checkerboard pattern of inner ear cells enables us to hear

A recent study published in Frontiers in Cell and Developmental Biology has found that the unique checkerboard pattern of cells in the organ of Corti is essential for proper hearing. The researchers discovered that when hair cells adhere to each other abnormally, it leads to apoptosis and a decrease in hair cell numbers, resulting in h...

SourceKobe University·JournalFrontiers in Cell and Developmental Biology·TypeExperimental study·DateDec 27, 2022

Radiation damage to paternal DNA is passed on to offspring

Researchers discovered that radiation damage to paternal DNA is passed on to offspring through a highly error-prone repair mechanism. This leads to structural changes in the paternal chromosomes and causes developmental defects. Histone proteins play a crucial role in shielding damaged chromosomes from accurate repair.

SourceUniversity of Cologne·JournalNature·TypeObservational study·DateDec 21, 2022

Discover the latest newborn screening research in the special issue American Journal of Medical Genetics

The special issue highlights innovation across various stakeholders in newborn screening, including researchers, healthcare professionals, and families. Key findings include the development of novel technologies to screen, diagnose, and treat newborns, as well as long-term follow-up studies and NBS expansion.

SourceNewborn Screening Translational Research Network·JournalAmerican Journal of Medical Genetics Part C Seminars in Medical Genetics·DateDec 15, 2022

Novel method with implications for treatment of Fukuyama muscular dystrophy, a widespread neuromuscular disorder

Researchers from Japan have developed an RNA interference method using antisense oligonucleotides to correct a genetic defect in Fukuyama Muscular Dystrophy. This approach has shown promise in treating patients with the disease, which is characterized by generalized muscle weakness and intellectual disability.

SourceFujita Health University·JournalHuman Molecular Genetics·TypeExperimental study·DateDec 12, 2022

Gene-delivering viruses reach the brain in step toward gene therapy for neurological diseases

Researchers have engineered a family of adeno-associated viral vectors that can deliver cargo to the primate brain, offering a safer and more efficient way to treat genetic diseases. The PAL family of AAVs has been shown to be three times better at delivering their cargo into the brain than current leading AAV delivery vehicle AAV9.

SourceBroad Institute of MIT and Harvard·JournalMed·TypeExperimental study·DateNov 22, 2022